International Myeloma Society/International Myeloma working group consensus recommendations on the definition of high-risk multiple myeloma

Despite significant improvements in survival of patients with multiple myeloma (MM), outcomes remain heterogeneous, and a significant proportion of patients experience suboptimal outcomes. Importantly, traditional prognostic factors based on data from patients treated with older therapies no longer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Avet-Loiseau, Hervé (VerfasserIn) , Davies, Faith E. (VerfasserIn) , Samur, Mehmet K. (VerfasserIn) , Corre, Jill (VerfasserIn) , D'Agostino, Mattia (VerfasserIn) , Kaiser, Martin F. (VerfasserIn) , Raab, Marc-Steffen (VerfasserIn) , Weinhold, Niels (VerfasserIn) , Gutierrez, Norma C. (VerfasserIn) , Paiva, Bruno (VerfasserIn) , Neri, Paola (VerfasserIn) , Weisel, Katja (VerfasserIn) , Maura, Francesco (VerfasserIn) , Walker, Brian A. (VerfasserIn) , Bustoros, Mark (VerfasserIn) , Stewart, A. Keith (VerfasserIn) , Usmani, Saad Z. (VerfasserIn) , Hillengass, Jens (VerfasserIn) , Chng, Wee Joo (VerfasserIn) , Keats, Jonathan J. (VerfasserIn) , Martinez-Lopez, Joaquin (VerfasserIn) , Sperling, Adam S. (VerfasserIn) , Touzeau, Cyrille (VerfasserIn) , Zhan, Fenghuang (VerfasserIn) , Raje, Noopur S. (VerfasserIn) , Cavo, Michele (VerfasserIn) , Bolli, Niccolò (VerfasserIn) , Ghobrial, Irene M. (VerfasserIn) , Dhodapkar, Madhav V. (VerfasserIn) , Jagannath, Sundar (VerfasserIn) , Spencer, Andrew (VerfasserIn) , Parekh, Samir (VerfasserIn) , Bahlis, Nizar J. (VerfasserIn) , Lonial, Sagar (VerfasserIn) , Sonneveld, Pieter (VerfasserIn) , Bergsagel, Leif (VerfasserIn) , Orlowski, Robert Z. (VerfasserIn) , Morgan, Gareth (VerfasserIn) , Mateos, María Victoria (VerfasserIn) , Rajkumar, S. Vincent (VerfasserIn) , Miguel, Jesus F. San (VerfasserIn) , Anderson, Kenneth C. (VerfasserIn) , Moreau, Philippe (VerfasserIn) , Kumar, Shaji (VerfasserIn) , Prósper, Felipe (VerfasserIn) , Munshi, Nikhil C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2025
In: Journal of clinical oncology
Year: 2025, Jahrgang: 43, Heft: 24, Pages: 2739-2751
ISSN:1527-7755
DOI:10.1200/JCO-24-01893
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO-24-01893
Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO-24-01893
Volltext
Verfasserangaben:Hervé Avet-Loiseau, MD, PhD, Faith E. Davies, MD, Mehmet K. Samur, PhD, Jill Corre, PharmD, PhD, Mattia D’Agostino, MD, Martin F. Kaiser, MD, Marc S. Raab, MD, Niels Weinhold, PhD, Norma C. Gutierrez, MD, PhD, Bruno Paiva, PhD, Paola Neri, MD, Katja Weisel, MD, Francesco Maura, MD, Brian A. Walker, PhD, Mark Bustoros, MD, A. Keith Stewart, MB, CHB, Saad Z. Usmani, MD, Jens Hillengass, MD, PhD, Wee Joo Chng, MD19, Jonathan J. Keats, PhD, Joaquin Martinez-Lopez, MD, Adam S. Sperling, MD, PhD, Cyrille Touzeau, MD, Fenghuang Zhan, PhD, Noopur S. Raje, MD, Michele Cavo, MD, Niccolò Bolli, MD, PhD, Irene M. Ghobrial, MD, Madhav V. Dhodapkar, MD, Sundar Jagannath, MD, Andrew Spencer, MD, Samir Parekh, MD, Nizar J. Bahlis, MD, Sagar Lonial, MD, Pieter Sonneveld, MD, PhD, Leif Bergsagel, MD, Robert Z. Orlowski, MD, PhD, Gareth Morgan, MD, María Victoria Mateos, MD, S. Vincent Rajkumar, MD, Jesus F. San Miguel, MD, Kenneth C. Anderson, MD, Philippe Moreau, MD, Shaji Kumar, MD, Felipe Prósper, MD, and Nikhil C. Munshi, MD

MARC

LEADER 00000naa a2200000 c 4500
001 1949959244
003 DE-627
005 20260122091603.0
007 cr uuu---uuuuu
008 260122s2025 xx |||||o 00| ||eng c
024 7 |a 10.1200/JCO-24-01893  |2 doi 
035 |a (DE-627)1949959244 
035 |a (DE-599)KXP1949959244 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Avet-Loiseau, Hervé  |e VerfasserIn  |0 (DE-588)1220121037  |0 (DE-627)1736496964  |4 aut 
245 1 0 |a International Myeloma Society/International Myeloma working group consensus recommendations on the definition of high-risk multiple myeloma  |c Hervé Avet-Loiseau, MD, PhD, Faith E. Davies, MD, Mehmet K. Samur, PhD, Jill Corre, PharmD, PhD, Mattia D’Agostino, MD, Martin F. Kaiser, MD, Marc S. Raab, MD, Niels Weinhold, PhD, Norma C. Gutierrez, MD, PhD, Bruno Paiva, PhD, Paola Neri, MD, Katja Weisel, MD, Francesco Maura, MD, Brian A. Walker, PhD, Mark Bustoros, MD, A. Keith Stewart, MB, CHB, Saad Z. Usmani, MD, Jens Hillengass, MD, PhD, Wee Joo Chng, MD19, Jonathan J. Keats, PhD, Joaquin Martinez-Lopez, MD, Adam S. Sperling, MD, PhD, Cyrille Touzeau, MD, Fenghuang Zhan, PhD, Noopur S. Raje, MD, Michele Cavo, MD, Niccolò Bolli, MD, PhD, Irene M. Ghobrial, MD, Madhav V. Dhodapkar, MD, Sundar Jagannath, MD, Andrew Spencer, MD, Samir Parekh, MD, Nizar J. Bahlis, MD, Sagar Lonial, MD, Pieter Sonneveld, MD, PhD, Leif Bergsagel, MD, Robert Z. Orlowski, MD, PhD, Gareth Morgan, MD, María Victoria Mateos, MD, S. Vincent Rajkumar, MD, Jesus F. San Miguel, MD, Kenneth C. Anderson, MD, Philippe Moreau, MD, Shaji Kumar, MD, Felipe Prósper, MD, and Nikhil C. Munshi, MD 
264 1 |c August 2025 
300 |b Illustrationen 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 09. Juni 2025 
500 |a Gesehen am 22.01.2026 
520 |a Despite significant improvements in survival of patients with multiple myeloma (MM), outcomes remain heterogeneous, and a significant proportion of patients experience suboptimal outcomes. Importantly, traditional prognostic factors based on data from patients treated with older therapies no longer capture prognosis accurately in the contemporary era of novel triplet or quadruplet therapies. Therefore, risk stratification requires refinement in the context of available and investigational treatment options in routine practice and clinical trials, respectively. The current identification of high-risk MM (HRMM) in routine practice is based on the Revised International Staging System, which stratifies patients using a combination of widely available serum biomarkers and chromosomal abnormalities assessed via fluorescence in situ hybridization. In recent years, a substantial body of evidence concerning additional clinical, biological, and molecular/genomic prognostic factors has accumulated, along with new MM risk stratification tools and consensus reports. The International Myeloma Society, along with the International Myeloma Working Group, convened an Expert Panel with the primary aim of revisiting the definition of HRMM and formulating a practical and data-driven consensus definition, based on new evidence from molecular/genomic assays, updated clinical data, and contemporary risk stratification concepts. The Panel proposes the following Consensus Genomic Staging (CGS) of HRMM which relies upon the presence of at least one of these abnormalities: (1) del(17p), with a cutoff of >20%clonal fraction, and/or TP53mutation; (2) an IgH translocation including t(4;14), t(14;16), or t(14;20) along with 1q1 and/or del(1p32); (3) monoallelic del(1p32) along with 1q1 or biallelic del(1p32); or (4) b2 microglobulin ≥5.5 mg/L with normal creatinine (<1.2 mg/dL). 
700 1 |a Davies, Faith E.  |e VerfasserIn  |4 aut 
700 1 |a Samur, Mehmet K.  |e VerfasserIn  |4 aut 
700 1 |a Corre, Jill  |e VerfasserIn  |4 aut 
700 1 |a D'Agostino, Mattia  |e VerfasserIn  |4 aut 
700 1 |a Kaiser, Martin F.  |e VerfasserIn  |4 aut 
700 1 |a Raab, Marc-Steffen  |d 1973-  |e VerfasserIn  |0 (DE-588)124052460  |0 (DE-627)706520998  |0 (DE-576)293998027  |4 aut 
700 1 |a Weinhold, Niels  |e VerfasserIn  |0 (DE-588)141225688  |0 (DE-627)626149576  |0 (DE-576)322607388  |4 aut 
700 1 |a Gutierrez, Norma C.  |e VerfasserIn  |4 aut 
700 1 |a Paiva, Bruno  |e VerfasserIn  |4 aut 
700 1 |a Neri, Paola  |e VerfasserIn  |4 aut 
700 1 |a Weisel, Katja  |e VerfasserIn  |4 aut 
700 1 |a Maura, Francesco  |e VerfasserIn  |4 aut 
700 1 |a Walker, Brian A.  |e VerfasserIn  |4 aut 
700 1 |a Bustoros, Mark  |e VerfasserIn  |4 aut 
700 1 |a Stewart, A. Keith  |e VerfasserIn  |4 aut 
700 1 |a Usmani, Saad Z.  |e VerfasserIn  |4 aut 
700 1 |a Hillengass, Jens  |e VerfasserIn  |4 aut 
700 1 |a Chng, Wee Joo  |e VerfasserIn  |4 aut 
700 1 |a Keats, Jonathan J.  |e VerfasserIn  |4 aut 
700 1 |a Martinez-Lopez, Joaquin  |e VerfasserIn  |4 aut 
700 1 |a Sperling, Adam S.  |e VerfasserIn  |4 aut 
700 1 |a Touzeau, Cyrille  |e VerfasserIn  |4 aut 
700 1 |a Zhan, Fenghuang  |e VerfasserIn  |4 aut 
700 1 |a Raje, Noopur S.  |e VerfasserIn  |4 aut 
700 1 |a Cavo, Michele  |e VerfasserIn  |4 aut 
700 1 |a Bolli, Niccolò  |e VerfasserIn  |4 aut 
700 1 |a Ghobrial, Irene M.  |e VerfasserIn  |4 aut 
700 1 |a Dhodapkar, Madhav V.  |e VerfasserIn  |4 aut 
700 1 |a Jagannath, Sundar  |e VerfasserIn  |4 aut 
700 1 |a Spencer, Andrew  |e VerfasserIn  |4 aut 
700 1 |a Parekh, Samir  |e VerfasserIn  |4 aut 
700 1 |a Bahlis, Nizar J.  |e VerfasserIn  |4 aut 
700 1 |a Lonial, Sagar  |e VerfasserIn  |4 aut 
700 1 |a Sonneveld, Pieter  |e VerfasserIn  |4 aut 
700 1 |a Bergsagel, Leif  |e VerfasserIn  |4 aut 
700 1 |a Orlowski, Robert Z.  |e VerfasserIn  |4 aut 
700 1 |a Morgan, Gareth  |e VerfasserIn  |4 aut 
700 1 |a Mateos, María Victoria  |e VerfasserIn  |4 aut 
700 1 |a Rajkumar, S. Vincent  |e VerfasserIn  |4 aut 
700 1 |a Miguel, Jesus F. San  |e VerfasserIn  |4 aut 
700 1 |a Anderson, Kenneth C.  |e VerfasserIn  |4 aut 
700 1 |a Moreau, Philippe  |e VerfasserIn  |4 aut 
700 1 |a Kumar, Shaji  |e VerfasserIn  |4 aut 
700 1 |a Prósper, Felipe  |e VerfasserIn  |4 aut 
700 1 |a Munshi, Nikhil C.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical oncology  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 43(2025), 24, Seite 2739-2751  |h Online-Ressource  |w (DE-627)313116962  |w (DE-600)2005181-5  |w (DE-576)090887018  |x 1527-7755  |7 nnas  |a International Myeloma Society/International Myeloma working group consensus recommendations on the definition of high-risk multiple myeloma 
773 1 8 |g volume:43  |g year:2025  |g number:24  |g pages:2739-2751  |g extent:16  |a International Myeloma Society/International Myeloma working group consensus recommendations on the definition of high-risk multiple myeloma 
856 4 0 |u https://doi.org/10.1200/JCO-24-01893  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext  |7 1 
856 4 0 |u https://ascopubs.org/doi/10.1200/JCO-24-01893  |x Verlag  |z lizenzpflichtig  |3 Volltext  |7 1 
951 |a AR 
992 |a 20260122 
993 |a Article 
994 |a 2025 
998 |g 141225688  |a Weinhold, Niels  |m 141225688:Weinhold, Niels  |d 910000  |d 910100  |d 50000  |e 910000PW141225688  |e 910100PW141225688  |e 50000PW141225688  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 8 
998 |g 124052460  |a Raab, Marc-Steffen  |m 124052460:Raab, Marc-Steffen  |d 910000  |d 910100  |e 910000PR124052460  |e 910100PR124052460  |k 0/910000/  |k 1/910000/910100/  |p 7 
999 |a KXP-PPN1949959244  |e 4857061120 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"International Myeloma Society/International Myeloma working group consensus recommendations on the definition of high-risk multiple myeloma","title_sort":"International Myeloma Society/International Myeloma working group consensus recommendations on the definition of high-risk multiple myeloma"}],"note":["Veröffentlicht: 09. Juni 2025","Gesehen am 22.01.2026"],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"origin":[{"publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedDisp":"1983-","dateIssuedKey":"1983"}],"recId":"313116962","physDesc":[{"extent":"Online-Ressource"}],"disp":"International Myeloma Society/International Myeloma working group consensus recommendations on the definition of high-risk multiple myelomaJournal of clinical oncology","id":{"eki":["313116962"],"zdb":["2005181-5"],"issn":["1527-7755"]},"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"title":[{"title_sort":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal","title":"Journal of clinical oncology"}],"part":{"volume":"43","year":"2025","text":"43(2025), 24, Seite 2739-2751","pages":"2739-2751","extent":"16","issue":"24"},"language":["eng"],"pubHistory":["1.1983 -"]}],"id":{"eki":["1949959244"],"doi":["10.1200/JCO-24-01893"]},"physDesc":[{"noteIll":"Illustrationen","extent":"16 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1949959244","origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"August 2025"}],"person":[{"family":"Avet-Loiseau","display":"Avet-Loiseau, Hervé","role":"aut","given":"Hervé"},{"family":"Davies","display":"Davies, Faith E.","role":"aut","given":"Faith E."},{"given":"Mehmet K.","role":"aut","display":"Samur, Mehmet K.","family":"Samur"},{"display":"Corre, Jill","given":"Jill","role":"aut","family":"Corre"},{"family":"D'Agostino","role":"aut","given":"Mattia","display":"D'Agostino, Mattia"},{"family":"Kaiser","display":"Kaiser, Martin F.","given":"Martin F.","role":"aut"},{"display":"Raab, Marc-Steffen","role":"aut","given":"Marc-Steffen","family":"Raab"},{"family":"Weinhold","role":"aut","given":"Niels","display":"Weinhold, Niels"},{"family":"Gutierrez","role":"aut","given":"Norma C.","display":"Gutierrez, Norma C."},{"given":"Bruno","role":"aut","display":"Paiva, Bruno","family":"Paiva"},{"family":"Neri","display":"Neri, Paola","role":"aut","given":"Paola"},{"given":"Katja","role":"aut","display":"Weisel, Katja","family":"Weisel"},{"family":"Maura","display":"Maura, Francesco","given":"Francesco","role":"aut"},{"family":"Walker","display":"Walker, Brian A.","given":"Brian A.","role":"aut"},{"display":"Bustoros, Mark","role":"aut","given":"Mark","family":"Bustoros"},{"family":"Stewart","given":"A. Keith","role":"aut","display":"Stewart, A. Keith"},{"display":"Usmani, Saad Z.","given":"Saad Z.","role":"aut","family":"Usmani"},{"display":"Hillengass, Jens","given":"Jens","role":"aut","family":"Hillengass"},{"role":"aut","given":"Wee Joo","display":"Chng, Wee Joo","family":"Chng"},{"display":"Keats, Jonathan J.","role":"aut","given":"Jonathan J.","family":"Keats"},{"family":"Martinez-Lopez","given":"Joaquin","role":"aut","display":"Martinez-Lopez, Joaquin"},{"display":"Sperling, Adam S.","role":"aut","given":"Adam S.","family":"Sperling"},{"family":"Touzeau","display":"Touzeau, Cyrille","role":"aut","given":"Cyrille"},{"role":"aut","given":"Fenghuang","display":"Zhan, Fenghuang","family":"Zhan"},{"family":"Raje","given":"Noopur S.","role":"aut","display":"Raje, Noopur S."},{"family":"Cavo","display":"Cavo, Michele","given":"Michele","role":"aut"},{"display":"Bolli, Niccolò","given":"Niccolò","role":"aut","family":"Bolli"},{"family":"Ghobrial","role":"aut","given":"Irene M.","display":"Ghobrial, Irene M."},{"family":"Dhodapkar","given":"Madhav V.","role":"aut","display":"Dhodapkar, Madhav V."},{"family":"Jagannath","display":"Jagannath, Sundar","role":"aut","given":"Sundar"},{"display":"Spencer, Andrew","role":"aut","given":"Andrew","family":"Spencer"},{"display":"Parekh, Samir","role":"aut","given":"Samir","family":"Parekh"},{"given":"Nizar J.","role":"aut","display":"Bahlis, Nizar J.","family":"Bahlis"},{"display":"Lonial, Sagar","role":"aut","given":"Sagar","family":"Lonial"},{"display":"Sonneveld, Pieter","given":"Pieter","role":"aut","family":"Sonneveld"},{"display":"Bergsagel, Leif","role":"aut","given":"Leif","family":"Bergsagel"},{"role":"aut","given":"Robert Z.","display":"Orlowski, Robert Z.","family":"Orlowski"},{"display":"Morgan, Gareth","given":"Gareth","role":"aut","family":"Morgan"},{"family":"Mateos","given":"María Victoria","role":"aut","display":"Mateos, María Victoria"},{"role":"aut","given":"S. Vincent","display":"Rajkumar, S. Vincent","family":"Rajkumar"},{"family":"Miguel","given":"Jesus F. San","role":"aut","display":"Miguel, Jesus F. San"},{"family":"Anderson","given":"Kenneth C.","role":"aut","display":"Anderson, Kenneth C."},{"family":"Moreau","display":"Moreau, Philippe","role":"aut","given":"Philippe"},{"family":"Kumar","role":"aut","given":"Shaji","display":"Kumar, Shaji"},{"role":"aut","given":"Felipe","display":"Prósper, Felipe","family":"Prósper"},{"role":"aut","given":"Nikhil C.","display":"Munshi, Nikhil C.","family":"Munshi"}],"name":{"displayForm":["Hervé Avet-Loiseau, MD, PhD, Faith E. Davies, MD, Mehmet K. Samur, PhD, Jill Corre, PharmD, PhD, Mattia D’Agostino, MD, Martin F. Kaiser, MD, Marc S. Raab, MD, Niels Weinhold, PhD, Norma C. Gutierrez, MD, PhD, Bruno Paiva, PhD, Paola Neri, MD, Katja Weisel, MD, Francesco Maura, MD, Brian A. Walker, PhD, Mark Bustoros, MD, A. Keith Stewart, MB, CHB, Saad Z. Usmani, MD, Jens Hillengass, MD, PhD, Wee Joo Chng, MD19, Jonathan J. Keats, PhD, Joaquin Martinez-Lopez, MD, Adam S. Sperling, MD, PhD, Cyrille Touzeau, MD, Fenghuang Zhan, PhD, Noopur S. Raje, MD, Michele Cavo, MD, Niccolò Bolli, MD, PhD, Irene M. Ghobrial, MD, Madhav V. Dhodapkar, MD, Sundar Jagannath, MD, Andrew Spencer, MD, Samir Parekh, MD, Nizar J. Bahlis, MD, Sagar Lonial, MD, Pieter Sonneveld, MD, PhD, Leif Bergsagel, MD, Robert Z. Orlowski, MD, PhD, Gareth Morgan, MD, María Victoria Mateos, MD, S. Vincent Rajkumar, MD, Jesus F. San Miguel, MD, Kenneth C. Anderson, MD, Philippe Moreau, MD, Shaji Kumar, MD, Felipe Prósper, MD, and Nikhil C. Munshi, MD"]}} 
SRT |a AVETLOISEAINTERNATIO2025